Lyfnua
Lyfnua is a medicine authorised by Swissmedic under authorisation number 68065. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 May 2022 and the authorisation is limited until 23 May 2027. ATC code R05DB29 places the medicine in the group Cough and cold preparations.
| Authorisation number | 68065 |
|---|---|
| Name | Lyfnua |
| Full name | Lyfnua, Filmtabletten |
| Authorisation holder | MSD Merck Sharp & Dohme AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R05DB29 |
| First authorisation | 24 May 2022 |
| Authorisation validity | 23 May 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lyfnua, Filmtabletten | B | 24 May 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 56 | Tablette(n) | R05DB29 | 03.01.2. | B |
| 3 | 196 | Tablette(n) | R05DB29 | 03.01.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Lyfnua authorised in Switzerland?
Yes. Lyfnua is authorised by Swissmedic under authorisation number 68065, data as of 01 September 2026. The authorisation is limited until 23 May 2027.
Which dispensing category does Lyfnua have?
Lyfnua is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lyfnua?
The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.